Stance Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-4,555
Closed -$1.35M – 356
2026
Q1
$1.35M Sell
4,555
-577
-11% -$171K 0.65% 63
2025
Q4
$1.4M Buy
5,132
+10
+0.2% +$2.72K 0.52% 73
2025
Q3
$1.38M Buy
5,122
+297
+6% +$80.8K 0.51% 71
2025
Q2
$1.33M Buy
+4,825
New +$1.31M 0.5% 101
2025
Q1
– Sell
-797
Closed -$185K – 97
2024
Q4
$185K Buy
+797
New +$183K 0.11% 71

Other funds holding CME

Stance Capital's CME Position: Q2 2026 in Review

Stance Capital sold out of CME Group (CME) in Q2 2026, closing a stake of 4,555 shares — an estimated $1.35M sold.

Stance Capital first reported a position in CME in Q4 2024 and held it in 5 quarters. The position peaked at $1.4M in Q4 2025. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Stance Capital reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • Stance Capital sold 4,555 CME Group shares in Q2 2026, an estimated $1.35M.
  • Stance Capital first reported a position in CME Group in Q4 2024 and held it in 5 quarters.
  • Stance Capital's CME Group position peaked at $1.4M in Q4 2025.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.